Search

Your search keyword '"Service de Néphrologie et Transplantation"' showing total 415 results

Search Constraints

Start Over You searched for: Author "Service de Néphrologie et Transplantation" Remove constraint Author: "Service de Néphrologie et Transplantation"
415 results on '"Service de Néphrologie et Transplantation"'

Search Results

1. Incidence of cytomegalovirus infection in seropositive kidney transplant recipients treated with everolimus: A randomized, open-label, multicenter phase 4 trial

2. Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression

3. Temporal trends in living kidney donation in France between 2007 and 2017

4. Survival and specific outcome of sickle cell disease patients after renal transplantation

5. PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study study protocol for a randomized controlled study

6. Résultats du Registre français des transplantés rénaux ayant développé une infection à SARS-CoV-2

7. Report on chronic dialysis in France in 2016

8. PHENOTYPIC STUDY OF KIDNEY TRANSPLANT PATIENTS PRESENTING DE NOVO DSA: A FRENCH MULTICENTER COHORT OF 96 CASES

9. Grams ME, Sang Y, Ballew SH, et al, for the Chronic Kidney Disease Prognosis Consortium. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018;93:1442–1451

10. A lack of significant effect of POR*28 allelic variant on tacrolimus exposure in kidney transplant recipients

11. A multicenter, randomized trial of increased mycophenolic acid dose using enteric-coated mycophenolate sodium with reduced tacrolimus exposure in maintenance kidney transplant recipients

12. The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients

13. Successful Reuse of Kidney Graft After Early Recurrence of Primary Focal and Segmental Glomerulosclerosis

14. Ostéopathies fragilisantes, maladie rénale chronique, malabsorptions, anomalies biologiques du métabolisme phosphocalcique : les bonnes indications pour un remboursement raisonné du dosage de vitamine D [Weakening osteopathies, chronic kidney disease, malabsorption, biological anomalies of calium/phosphorus metabolism: appropriate indications for a reasoned reimbursment of serum vitamin D measurement]

15. Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival

16. Impact of Covid-19 on kidney transplant and waiting list patients: Lessons from the first wave of the pandemic

17. Five-year results of a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation: the SPIESSER study

18. Efficacy and safety of early cyclosporine conversion to sirolimus with continued MMF-four-year results of the Postconcept study

19. Longitudinal evaluation of the impact of immunosuppressive regimen on immune responses to COVID-19 vaccination in kidney transplant recipients

20. Living kidney donor evaluation for all candidates with normal estimated GFR for age

21. Renal function with delayed or immediate cyclosporine microemulsion in combination with enteric-coated mycophenolate sodium and steroids: results of follow up to 30 months post-transplant

22. A Randomized Prospective Study Comparing Anti–T-Lymphocyte Igs to Basiliximab in Highly Sensitized Kidney Transplant Patients

23. Vaccination and COVID-19 Dynamics in Dialysis Patients

24. Impact of Tacrolimus Daily Dose Limitation in Renal Transplant Recipients Expressing CYP3A5: A Retrospective Study

25. MUC1 Mitigates Renal Injury and Inflammation in Endotoxin-Induced Acute Kidney Injury by Inhibiting the TLR4-MD2 Axis and Reducing Pro-inflammatory Macrophages Infiltration

26. Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre

27. Barriers to conservative care from patients' and nephrologists' perspectives: the CKD-REIN study

28. Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation

29. Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study

30. Heme Oxygenase 1: A Defensive Mediator in Kidney Diseases

31. External Validation of the DynPG for Kidney Transplant Recipients

32. De Novo Focal and Segmental Glomerulosclerosis After COVID-19 in a Patient With a Transplanted Kidney From a Donor With a High-risk APOL1 Variant

33. Comparison of Plasma Clearance With Early-Compartment Correction Equations and Urinary Clearance in High GFR Ranges

34. Short- and long-term renal outcomes following severe rhabdomyolysis: a French multicenter retrospective study of 387 patients

35. Gangliosides in Podocyte Biology and Disease

36. A sensitive S-Trap-based approach to the analysis of T cell lipid raft proteome

37. Hepatitis E Virus: How It Escapes Host Innate Immunity

38. Imported Malaria, Collapsing Glomerulopathy, and Focal and Segmental Glomerulosclerosis

39. Haemolytic uraemic syndrome

40. Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN

41. Hemolysis Derived Products Toxicity and Endothelium: Model of the Second Hit

42. Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes

43. Lack of impact of pre-emptive deceased-donor kidney transplantation on graft outcomes: a propensity score-based study

44. Hepatitis E virus replication in human intestinal cells

45. Transplant center characteristics associated with living‐donor kidney transplantation: a cohort study with a hierarchical modeling approach

46. Extracorporeal photopheresis for the treatment of graft rejection in 33 adult kidney transplant recipients

47. Impact of hypertensive emergency and complement rare variants on presentation and outcome of atypical hemolytic uremic syndrome

48. Endothelium structure and function in kidney health and disease

49. Risk Factors for Early Graft Failure and Death After Kidney Transplantation in Recipients Older Than 70 Years

50. Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study

Catalog

Books, media, physical & digital resources